DZ2181A1 - Dénvés d'oxadiazole et de thiadiazole antagonistesdes récepteurs muscariniques. - Google Patents
Dénvés d'oxadiazole et de thiadiazole antagonistesdes récepteurs muscariniques.Info
- Publication number
- DZ2181A1 DZ2181A1 DZ970027A DZ970027A DZ2181A1 DZ 2181 A1 DZ2181 A1 DZ 2181A1 DZ 970027 A DZ970027 A DZ 970027A DZ 970027 A DZ970027 A DZ 970027A DZ 2181 A1 DZ2181 A1 DZ 2181A1
- Authority
- DZ
- Algeria
- Prior art keywords
- oxadiazole
- receptor antagonist
- muscarinic receptor
- thiadiazole derivatives
- thiadiazole
- Prior art date
Links
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 title 1
- 239000003149 muscarinic antagonist Substances 0.000 title 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 title 1
- 150000004867 thiadiazoles Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9603755.1A GB9603755D0 (en) | 1996-02-22 | 1996-02-22 | Therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DZ2181A1 true DZ2181A1 (fr) | 2002-12-01 |
Family
ID=10789217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DZ970027A DZ2181A1 (fr) | 1996-02-22 | 1997-02-19 | Dénvés d'oxadiazole et de thiadiazole antagonistesdes récepteurs muscariniques. |
Country Status (42)
| Country | Link |
|---|---|
| US (1) | US5977142A (fr) |
| EP (1) | EP0885218B1 (fr) |
| JP (1) | JP3148252B2 (fr) |
| KR (1) | KR100315934B1 (fr) |
| CN (1) | CN1089340C (fr) |
| AP (1) | AP751A (fr) |
| AR (1) | AR005916A1 (fr) |
| AT (1) | ATE200899T1 (fr) |
| AU (1) | AU712230B2 (fr) |
| BG (2) | BG63971B1 (fr) |
| BR (1) | BR9707733A (fr) |
| CA (1) | CA2247164C (fr) |
| CO (1) | CO4650040A1 (fr) |
| CZ (1) | CZ292650B6 (fr) |
| DE (1) | DE69704701T2 (fr) |
| DK (1) | DK0885218T3 (fr) |
| DZ (1) | DZ2181A1 (fr) |
| ES (1) | ES2156357T3 (fr) |
| GB (1) | GB9603755D0 (fr) |
| GR (1) | GR3036032T3 (fr) |
| HN (1) | HN1997000020A (fr) |
| HR (1) | HRP970098B1 (fr) |
| HU (1) | HUP9900501A3 (fr) |
| ID (1) | ID16642A (fr) |
| IL (1) | IL125413A (fr) |
| IS (1) | IS4803A (fr) |
| MY (1) | MY129729A (fr) |
| NO (1) | NO313414B1 (fr) |
| NZ (1) | NZ331039A (fr) |
| OA (1) | OA10838A (fr) |
| PE (1) | PE42798A1 (fr) |
| PL (1) | PL186879B1 (fr) |
| PT (1) | PT885218E (fr) |
| RU (1) | RU2162848C2 (fr) |
| SK (1) | SK283461B6 (fr) |
| TN (1) | TNSN97039A1 (fr) |
| TR (1) | TR199801644T2 (fr) |
| TW (1) | TW492961B (fr) |
| UA (1) | UA61068C2 (fr) |
| WO (1) | WO1997030994A1 (fr) |
| YU (1) | YU35698A (fr) |
| ZA (1) | ZA971513B (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6107313A (en) * | 1998-10-02 | 2000-08-22 | Combichem, Inc. | Dopamine receptor antagonists |
| KR100838447B1 (ko) * | 2001-02-21 | 2008-06-16 | 아스트라제네카 아베 | 헤테로폴리시클릭 화합물 및 대사향성 글루타메이트수용체 길항제로서의 그의 용도 |
| GB0510139D0 (en) * | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B1 |
| GB0510141D0 (en) * | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B3 |
| GB0516313D0 (en) | 2005-08-08 | 2005-09-14 | Argenta Discovery Ltd | Azole derivatives and their uses |
| WO2008017827A2 (fr) * | 2006-08-08 | 2008-02-14 | Argenta Discovery Limited | Composés chimiques |
| WO2008023157A1 (fr) * | 2006-08-21 | 2008-02-28 | Argenta Discovery Limited | Composés et leur utilisation |
| WO2008096093A1 (fr) * | 2007-02-06 | 2008-08-14 | Argenta Discovery Ltd. | Dérivés d'oxazole et de thiazole et leurs utilisations |
| GB0702416D0 (en) * | 2007-02-07 | 2007-03-21 | Argenta Discovery Ltd | New combination |
| CA2675629A1 (fr) * | 2007-02-07 | 2008-08-14 | Argenta Discovery Ltd | Sel inedit |
| GB0702385D0 (en) * | 2007-02-07 | 2007-03-21 | Argenta Discovery Ltd | New combination |
| GB0702414D0 (en) * | 2007-02-07 | 2007-03-21 | Argenta Discovery Ltd | Oxazole and thiazole derivatives and their uses 2 |
| GB0702382D0 (en) * | 2007-02-07 | 2007-03-21 | Argenta Discovery Ltd | New salt |
| JP2010519193A (ja) * | 2007-02-15 | 2010-06-03 | アージェンタ ディスカバリー リミテッド | Ｍ３ムスカリン受容体としての複素環式誘導体 |
| WO2009098453A1 (fr) * | 2008-02-06 | 2009-08-13 | Astrazeneca Ab | Azonia bicycloalcanes comme antagonistes du récepteur d'acétylcholine muscarinique m3 |
| US8263623B2 (en) | 2008-07-11 | 2012-09-11 | Pfizer Inc. | Triazol derivatives useful for the treatment of diseases |
| WO2010018352A1 (fr) * | 2008-08-12 | 2010-02-18 | Argenta Discovery Limited | Composés hétérocycliques utilisés dans le traitement de maladies impliquant l’activation améliorée du récepteur m3 |
| JP2014065387A (ja) * | 2012-09-25 | 2014-04-17 | Showa Corp | 自動二輪車の車高調整装置 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ219646A (en) * | 1986-03-27 | 1990-10-26 | Merck Sharp & Dohme | Oxadiazole derivatives of azacyclics for treating cns disorders |
| IL88846A0 (en) * | 1988-01-08 | 1989-07-31 | Merck Sharp & Dohme | Lipophilic oxadiazoles,their preparation and pharmaceutical compositions containing them |
| US5043345A (en) * | 1989-02-22 | 1991-08-27 | Novo Nordisk A/S | Piperidine compounds and their preparation and use |
| JPH07502529A (ja) * | 1991-12-31 | 1995-03-16 | 藤沢薬品工業株式会社 | アセチルコリンエステラーゼ阻害およびムスカリン様のアゴニスト活性を有するオキサジアゾール誘導体 |
| TW360653B (en) * | 1995-03-01 | 1999-06-11 | Janssen Pharmaceutica Nv | A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition |
-
1996
- 1996-02-22 GB GBGB9603755.1A patent/GB9603755D0/en active Pending
-
1997
- 1997-01-21 TW TW086100642A patent/TW492961B/zh not_active IP Right Cessation
- 1997-02-03 HN HN1997000020A patent/HN1997000020A/es unknown
- 1997-02-04 NZ NZ331039A patent/NZ331039A/en unknown
- 1997-02-04 US US09/117,556 patent/US5977142A/en not_active Expired - Fee Related
- 1997-02-04 CN CN97192486A patent/CN1089340C/zh not_active Expired - Fee Related
- 1997-02-04 EP EP97902337A patent/EP0885218B1/fr not_active Expired - Lifetime
- 1997-02-04 BR BR9707733A patent/BR9707733A/pt not_active Application Discontinuation
- 1997-02-04 PL PL97328633A patent/PL186879B1/pl not_active IP Right Cessation
- 1997-02-04 KR KR1019980706534A patent/KR100315934B1/ko not_active Expired - Fee Related
- 1997-02-04 RU RU98117457/04A patent/RU2162848C2/ru not_active IP Right Cessation
- 1997-02-04 WO PCT/EP1997/000525 patent/WO1997030994A1/fr not_active Ceased
- 1997-02-04 PT PT97902337T patent/PT885218E/pt unknown
- 1997-02-04 CZ CZ19982678A patent/CZ292650B6/cs not_active IP Right Cessation
- 1997-02-04 HU HU9900501A patent/HUP9900501A3/hu unknown
- 1997-02-04 DK DK97902337T patent/DK0885218T3/da active
- 1997-02-04 JP JP52974197A patent/JP3148252B2/ja not_active Expired - Fee Related
- 1997-02-04 ES ES97902337T patent/ES2156357T3/es not_active Expired - Lifetime
- 1997-02-04 CA CA002247164A patent/CA2247164C/fr not_active Expired - Fee Related
- 1997-02-04 DE DE69704701T patent/DE69704701T2/de not_active Expired - Fee Related
- 1997-02-04 AU AU16014/97A patent/AU712230B2/en not_active Ceased
- 1997-02-04 AT AT97902337T patent/ATE200899T1/de not_active IP Right Cessation
- 1997-02-04 TR TR1998/01644T patent/TR199801644T2/xx unknown
- 1997-02-04 IL IL12541397A patent/IL125413A/en not_active IP Right Cessation
- 1997-02-04 SK SK1123-98A patent/SK283461B6/sk unknown
- 1997-02-13 CO CO97007550A patent/CO4650040A1/es unknown
- 1997-02-14 PE PE1997000104A patent/PE42798A1/es not_active Application Discontinuation
- 1997-02-19 DZ DZ970027A patent/DZ2181A1/fr active
- 1997-02-19 TN TNTNSN97039A patent/TNSN97039A1/fr unknown
- 1997-02-20 AR ARP970100667A patent/AR005916A1/es unknown
- 1997-02-20 AP APAP/P/1997/000930A patent/AP751A/en active
- 1997-02-20 HR HR970098A patent/HRP970098B1/xx not_active IP Right Cessation
- 1997-02-21 MY MYPI97000654A patent/MY129729A/en unknown
- 1997-02-21 ID IDP970521A patent/ID16642A/id unknown
- 1997-02-21 ZA ZA971513A patent/ZA971513B/xx unknown
- 1997-04-02 UA UA98094939A patent/UA61068C2/uk unknown
-
1998
- 1998-07-21 IS IS4803A patent/IS4803A/is unknown
- 1998-08-14 OA OA9800143A patent/OA10838A/en unknown
- 1998-08-19 BG BG102699A patent/BG63971B1/bg unknown
- 1998-08-19 BG BG102699A patent/BG102699A/xx unknown
- 1998-08-21 NO NO19983871A patent/NO313414B1/no not_active IP Right Cessation
- 1998-08-21 YU YU35698A patent/YU35698A/sh unknown
-
2001
- 2001-06-13 GR GR20010400885T patent/GR3036032T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DZ2181A1 (fr) | Dénvés d'oxadiazole et de thiadiazole antagonistesdes récepteurs muscariniques. | |
| EP0934305A4 (fr) | Antagonistes de l'integrine | |
| EP0946164A4 (fr) | Antagonistes de l'integrine | |
| DE69719354D1 (de) | Muscarin-antagonisten | |
| EP0865867A4 (fr) | Dispositif d'usinage | |
| EP1007026A4 (fr) | Antagonistes d'integrine | |
| FR2765931B1 (fr) | Dispositif d'amortissement | |
| NO972016D0 (no) | Indolyl-Y-reseptorantagonister | |
| DE69734833D1 (de) | Vitronektin rezeptor antagonisten | |
| DE69728392D1 (de) | Indolderivate verwendbar als endothelinrezeptorantagonisten | |
| EP1100506A4 (fr) | Antagonistes des recepteurs de l'integrine | |
| EP0612244A4 (fr) | Antagonistes recepteurs de l'endotheline. | |
| DZ1773A1 (fr) | Antagonistes de récepteurs d'endothéline. | |
| EP0810994A4 (fr) | Antagonistes des recepteurs de fibrinogene | |
| GB9020051D0 (en) | Muscarinic receptor antagonists | |
| NO975976L (no) | Vitronektinreseptor-antagonister, fremstilling samt anvendelse derav | |
| EP0885205A4 (fr) | Antagonistes des recepteurs de fibrinogenes | |
| NO975975D0 (no) | Vitronektinreseptor-antagonister, fremstilling samt anvendelse derav | |
| TR199800988A3 (tr) | 5' Deoksi-Sitidin türevleri. | |
| EP0684823A4 (fr) | Antagonistes des recepteurs de fibrinogene. | |
| FR2748318B1 (fr) | Dispositif d'injection de plasma | |
| FI894675A7 (fi) | Muskarinreceptorantagonister. | |
| DE69616364D1 (de) | Endothelinrezeptorantagonisten | |
| EP0999205A4 (fr) | Composes d'aminocycloalcane | |
| FI950209L (fi) | Farmakologisesti aktiiviset alfa-(tertiaarinen-amino-metyyli)-bentseenimetanolijohdannaiset |